SCHEMBL4541506

SCHEMBL4541506

CC(C)(C)c1ccc(C=NO)c(OCC(=O)O)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.57
POLB P06746 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
TSHR P16473 1/20 0.54
CTDSP1 Q9GZU7 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 1/20 0.49
CD69 Q07108 2/20 0.46
ELANE P08246 1/20 0.46
USP2 O75604 1/20 0.44
PTGDR2 Q9Y5Y4 5/20 0.44
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
FFAR1 O14842 1/20 0.39
EPHX2 P34913 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380943 0.85 CYP2C19 (0.61) CYP2C19POLBL3MBTL1SMN1; SMN2MAPT
SCHEMBL13757719 0.79 CYP2C19 (0.74) CYP2C19POLBTDP1TSHRL3MBTL1
SCHEMBL4541508 0.79 MAPT (0.53) CYP2C19TSHRL3MBTL1SMN1; SMN2MAPT
SCHEMBL13580642 0.77 CYP2C19 (0.66) CYP2C19POLBTDP1TSHRL3MBTL1
SCHEMBL4541504 0.77 MAPT (0.50) CYP2C19POLBTDP1TSHRCTDSP1
SCHEMBL4541510 0.77 MAPT (0.50) CYP2C19POLBTDP1TSHRCTDSP1
SCHEMBL4642604 0.76 CYP2C19 (0.65) CYP2C19POLBTDP1TSHRCTDSP1
SCHEMBL13624055 0.76 CYP2C19 (0.68) CYP2C19POLBL3MBTL1SMN1; SMN2CD69
SCHEMBL13141657 0.76 CYP2C19 (0.64) CYP2C19TDP1TSHRL3MBTL1SMN1; SMN2
SCHEMBL17896571 0.75 CYP2C19 (0.72) CYP2C19SMN1; SMN2CD69ELANEPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009081222-A1 SUBSTITUTED TRICYCLIC PYRIDINE OR PYRIMIDINE VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-02 WO disclosed